World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
28969
World Ranking
3923
National Ranking
1797

Roza Nurieva publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Roza Nurieva sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 144 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Roza Nurieva D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Roza Nurieva sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Roza Nurieva is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their work spans multiple areas within medicine, focusing primarily on immunology and microbiology. The scientist's research interests include oncology, molecular biology, pulmonary and respiratory medicine, and psychiatry and mental health, reflecting a multidisciplinary approach to biomedical sciences.

Nurieva's publications highlight research topics such as cancer immunotherapy and biomarkers, immune cell function and interaction, immunotherapy and immune responses, immune cells in cancer, CAR-T cell therapy research, cancer-related stress and immune response, and neutropenia and cancer infections.

Some of the recent papers authored or coauthored by Nurieva include:

  • Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity (2022, Cancer Cell)
  • Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy (2022, Nature Communications)
  • Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications (2021, Frontiers in Immunology)
  • Interleukin-6 Blockade Abrogates Immunotherapy Toxicity and Promotes Tumor Immunity (2021, SSRN Electronic Journal)
  • Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer (2022, Radiotherapy and Oncology)

Frequent coauthors in Nurieva's research include Adi Diab, Noha Abdel-Wahab, Sang T. Kim, Jared K. Burks, and Michael A. Davies. These collaborations have contributed to a consistent output in a range of journals and scientific communications.

The main publication venues for Nurieva's work are:

  • The Journal of Immunology
  • Nature Communications
  • Cancer Research
  • Cancer Cell
  • Frontiers in Immunology

Across these publications, Nurieva explores mechanisms of immune response regulation in cancer therapy, effects of immune checkpoint inhibitors, and pulmonary adverse events related to oncologic treatments. Their focus on interleukin-6 and immune toxicity indicates a specific interest in modulating immune responses to improve therapeutic outcomes.

Best Publications

  • A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

    Heon Park;Zhaoxia Li;Xuexian O. Yang;Seon Hee Chang

  • T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ

    Xuexian O. Yang;Bhanu P. Pappu;Roza Nurieva;Askar Akimzhanov

  • Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

    Roza Nurieva;Xuexian O. Yang;Gustavo Martinez;Yongliang Zhang

  • STAT3 REGULATES CYTOKINE-MEDIATED GENERATION OF INFLAMMATORY HELPER T CELLS

    Xuexian O. Yang;Athanasia D. Panopoulos;Roza Nurieva;Seon Hee Chang

  • Bcl6 Mediates the Development of T Follicular Helper Cells

    Roza I. Nurieva;Yeonseok Chung;Gustavo J. Martinez;Xuexian O. Yang

  • Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling

    Yeonseok Chung;Seon Hee Chang;Gustavo J. Martinez;Xuexian O. Yang

  • Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell Lineages

    Roza I. Nurieva;Yeonseok Chung;Daehee Hwang;Xuexian O. Yang

  • Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs

    Xuexian O. Yang;Roza Nurieva;Gustavo J. Martinez;Hong Soon Kang

  • Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions

    Yeonseok Chung;Yeonseok Chung;Shinya Tanaka;Fuliang Chu;Roza I. Nurieva

  • Regulation of inflammatory responses by IL-17F.

    Xuexian O. Yang;Seon Hee Chang;Heon Park;Roza Nurieva

  • CCR6 regulates the migration of inflammatory and regulatory T cells.

    Tomohide Yamazaki;Xuexian O. Yang;Yeonseok Chung;Atsushi Fukunaga

  • Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction.

    Xindong Liu;Yun Wang;Huiping Lu;Jing Li

  • Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.

    Unknown

  • A Genomic Regulatory Element That Directs Assembly and Function of Immune-Specific AP-1–IRF Complexes

    Elke Glasmacher;Smita Agrawal;Abraham B. Chang;Theresa L. Murphy

  • Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development

    Xindong Liu;Xindong Liu;Xin Chen;Bo Zhong;Bo Zhong;Aibo Wang;Aibo Wang

  • Toll-like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease

    Joseph M. Reynolds;Bhanu P. Pappu;Juan Peng;Gustavo J. Martinez;Gustavo J. Martinez

  • T‐cell tolerance or function is determined by combinatorial costimulatory signals

    Roza Nurieva;Sunil Thomas;Thang Nguyen;Natalia Martin-Orozco

  • Bcl6 expression specifies the T follicular helper cell program in vivo

    Xindong Liu;Xiaowei Yan;Bo Zhong;Roza I. Nurieva

  • STAT5 Protein Negatively Regulates T Follicular Helper (Tfh) Cell Generation and Function

    Roza I. Nurieva;Andrew Podd;Andrew Podd;Yuhong Chen;Andrei M. Alekseev

  • Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice

    Hong Qin;Beatrisa Lerman;Ippei Sakamaki;Guowei Wei

  • Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell Lineages (DOI: 10.1016/j.immuni.2008.05.009)

    Roza I. Nurieva;Yeonseok Chung;Daehee Hwang;Xuexian O. Yang

Frequent Co-Authors

Chen Dong
Chen Dong Tsinghua University
Yeonseok Chung
Yeonseok Chung Seoul National University
Stephanie S. Watowich
Stephanie S. Watowich The University of Texas MD Anderson Cancer Center
Anton M. Jetten
Anton M. Jetten National Institutes of Health
Cara Haymaker
Cara Haymaker The University of Texas MD Anderson Cancer Center
Shinya Tanaka
Shinya Tanaka Hokkaido University
Shao Cong Sun
Shao Cong Sun The University of Texas MD Anderson Cancer Center
Richard A. Flavell
Richard A. Flavell Yale University
Tomohiro Kurosaki
Tomohiro Kurosaki Osaka University
Demin Wang
Demin Wang Medical College of Wisconsin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various allied health career paths, including advanced nursing roles that integrate immunological knowledge. For those interested in mental health, exploring the best psychiatric mental health nurse practitioner programs online can provide comprehensive training paired with strong clinical placement support to advance in specialized care. Affordability is also a key consideration—many students prioritize affordable pmhnp programs to balance quality education with financial planning.

For graduates aiming to understand salary prospects, reviewing the dnp salary by state offers valuable insight into potential income variations based on geographic location. Additionally, immunology-focused nurses looking to expand their scope can look into specialized transitions, such as the fnp to acute care np bridge program, which facilitates a smooth shift into acute care settings—often requiring in-depth knowledge of immune system function.

Overall, understanding these linked pathways and programs can help students and professionals craft a targeted educational and career plan, maximizing both expertise and employment opportunities in immunology-related fields.

Best Scientists Citing Roza Nurieva

Trending Scientists

Recently Published Articles